AbbVie Inc (BSP:ABBV34)
R$ 69.32 0 (0%) Market Cap: 1.97 Til Enterprise Value: 2.37 Til PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 80/100

Q4 2021 Abbvie Inc Earnings Call Transcript

Feb 02, 2022 / 02:00PM GMT
Release Date Price: R$45.59 (+1.49%)
Operator

Good morning and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions) I would now like to introduce Ms. Liz Shea, Vice President, Head of Investor Relations.

Elizabeth Shea
AbbVie Inc. - VP of IR

Good morning and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Rob Michael, Vice Chairman, Finance and Commercial Operations and Chief Financial Officer; and Jeff Stewart, Executive Vice President, Chief Commercial Officer. Joining us for the Q&A portion of the call is Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary.

Before we get started, some statements we make today may be considered forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot